down arrow

Neurocrine Biosciences, Inc.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US64125C1099
  • NASDAQ: NBIX
USD
142.25
-1.71 (-1.19%)

Sep 22

NAS

 View all stocks in this country
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryNeurocrine Biosciences, Inc. VS Pharmaceuticals & Biotechnology
 
calendar-icon
calendar-icon
1D
-1.19%
0%
1W
-5.18%
2.36%
1M
-6.76%
1.18%
YTD
0.3%
13.43%
1Y
-2.98%
16%
3Y
25.07%
79.73%
5Y
50.9%
76.64%
10Y
162.65%
256.64%
  • Stock Absolute Returns
  • S&P 500Absolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-11.98%
0%
-11.98%
6 Months
11.41%
0%
11.41%
1 Year
-2.98%
0%
-2.98%
2 Years
20.19%
0%
20.19%
3 Years
25.07%
0%
25.07%
4 Years
37.65%
0%
37.65%
5 Years
50.9%
0%
50.9%

Neurocrine Biosciences, Inc. for the last several years.

stock-summaryRisk Adjusted Returns v/s S&P 500
Footer loading